{"transactions":[{"id":1935850,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":115023,"kind":"person","name":"Marshall Margaret","position":1,"cik":"0001851634","reported_name":"Marshall Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2023-03-29T16:45:38.000Z","date":"2023-01-03","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":60000,"derivative":{"exercise_price":2.4,"expiration_date":"2033-01-03","underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-23-038365","document":"tm2310913-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851634/000110465923038365/tm2310913-3_4seq1.xml","form_type":"4"}},{"id":2401975,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":115023,"kind":"person","name":"Marshall Margaret","position":1,"cik":"0001851634","reported_name":"Marshall Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-02-11T19:55:15.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":80000,"derivative":{"exercise_price":11.12,"expiration_date":"2032-01-03","underlying":"Ordinary Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-22-020826","document":"tm226469-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851634/000110465922020826/tm226469-6_4seq1.xml","form_type":"4"}},{"id":2730523,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":115023,"kind":"person","name":"Marshall Margaret","position":1,"cik":"0001851634","reported_name":"Marshall Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2021-05-04T20:24:28.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":225570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on April 29, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":225570,"derivative":{"exercise_price":17,"expiration_date":"2031-04-29","underlying":"Ordinary Shares","underlying_shares":225570},"source":{"system":"sec-edgar","filing":"0001104659-21-061222","document":"tm2114558-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851634/000110465921061222/tm2114558-18_4seq1.xml","form_type":"4"}},{"id":2730522,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":115023,"kind":"person","name":"Marshall Margaret","position":1,"cik":"0001851634","reported_name":"Marshall Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2021-05-04T20:24:28.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":7783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on April 29, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7783,"derivative":{"exercise_price":17,"expiration_date":"2031-04-29","underlying":"Ordinary Shares","underlying_shares":7783},"source":{"system":"sec-edgar","filing":"0001104659-21-061222","document":"tm2114558-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851634/000110465921061222/tm2114558-18_4seq1.xml","form_type":"4"}}]}